Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Easy BioXKRX:353810 -3.22%91 OCF Margin % is 8.70% as of Jun. 2026, which is 4% below its 10-year median of 9.07. GuruFocus rates XKRX:353810 with a GF Score™ of 91/100 and a GF Value™ of ₩7,883.07 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 961 Biotechnology companies, Easy Bio ranks better than 74.82% on this metric.
The historical data trend for Easy Bio's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:353810 vs VRTX, REGN, MRNA: OCF Margin % Comparison
For the Biotechnology subindustry, Easy Bio's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Easy Bio OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Easy Bio's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Easy Bio's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Easy Bio (XKRX:353810) has a OCF Margin % of 8.70% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Easy Bio and its competitors. This is near median its historical median of 9.07. According to the industry distribution chart, Easy Bio ranks #242 out of 961 companies in the Biotechnology industry, placing it in the top 25.2%.
Is Easy Bio's OCF Margin % too high?
Easy Bio's current OCF Margin % of 8.70% is near median its 10-year median of 9.07. Based on the distribution chart, Easy Bio ranks #242 out of 961 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Easy Bio has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Easy Bio's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Easy Bio ranks #242 out of 961 companies for OCF Margin %. This puts Easy Bio in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Easy Bio and its competitors. Easy Bio's current OCF Margin % is 8.70%, which is near median its own 10-year median of 9.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Easy Bio stock overvalued right now?
Based on GuruFocus' analysis, Easy Bio (XKRX:353810) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩7,883.07, compared to a current price of ₩6,610.00 — trading 16.1% below its estimated fair value. The current OCF Margin % is 8.70%, which is near median its 10-year median of 9.07. Easy Bio's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Easy Bio (XKRX:353810), the current OCF Margin % is 8.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Easy Bio (XKRX:353810) Overvalued in 2026?
Based on GuruFocus' analysis, Easy Bio stock appears to be undervalued.
The current stock price of ₩6,610.00 is trading 16.1% below its estimated GF Value™ of ₩7,883.07.
GuruFocus considers Easy Bio to be Modestly Undervalued.
Key valuation signals for XKRX:353810:
OCF Margin %: 8.70% (near median its 10-year median of 9.07)
GF Value™: ₩7,883.07 vs. price of ₩6,610.00 (16.1% below fair value)
No single metric tells the full story. See the XKRX:353810 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:353810 has been successfully added to your 
